论文部分内容阅读
目的:分析阿托伐他汀钙治疗慢性硬膜下血肿的疗效。方法:选取本院2015年11月—2016年11月收治的96例慢性硬膜下血肿患者作为样本,将其分为治疗组(48例)与对照组(48例)。对照组采用常规钻孔引流术治疗,治疗组采用阿托伐他汀钙治疗。观察两组患者治疗前后日常生活自理能力评分、并发症发生情况及治疗有效情况。结果:治疗后,治疗组患者自理能力评分(69.62±4.76)、并发症发生率2.08%,治疗有效率97.91%,与对照组相比,优势显著(p<0.05)。结论:阿托伐他汀钙用于治疗慢性硬膜下血肿,可有效提高患者生活自理能力,降低并发症发生几率,提高治疗安全性与治疗有效率,临床应用价值显著。
Objective: To analyze the effect of atorvastatin calcium on chronic subdural hematoma. Methods: A total of 96 patients with chronic subdural hematoma who were treated in our hospital from November 2015 to November 2016 were selected and divided into treatment group (48 cases) and control group (48 cases). The control group was treated by conventional drilling and drainage, and the treatment group was treated with atorvastatin calcium. Observed two groups of patients before and after treatment daily living ability score, complications and treatment of effective. Results: After treatment, the self-care ability score (69.62 ± 4.76), the complication rate 2.08% and the treatment effective rate 97.91% in treatment group were significantly higher than those in control group (p <0.05). Conclusion: Atorvastatin calcium for the treatment of chronic subdural hematoma, which can effectively improve patients’ self-care ability, reduce the incidence of complications, improve the safety of treatment and treatment efficiency, clinical value is significant.